We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Nurix Therapeutics
NRIX
$2.65B
| $931K | ﹤0.01% |
31,074
+1,258
| +4% | +$38.8K |
|
2252
El Pollo Loco
LOCO
$462M
| $930K | ﹤0.01% |
55,048
-5,799
| -10% | -$105K |
|
2253
Personalis
PSNL
$1.51B
| $930K | ﹤0.01% |
48,349
+1,642
| +4% | +$34.3K |
|
|
PLYM
2254
DELISTED
Plymouth Industrial REIT
PLYM
| $929K | ﹤0.01% |
40,816
+2,583
| +7% | +$58K |
|
2255
Barnes & Noble Education
BNED
$443M
| $927K | ﹤0.01% |
928
-49
| -5% | -$43.2K |
|
2256
UNIFI
UFI
$134M
| $926K | ﹤0.01% |
42,221
-6,169
| -13% | -$140K |
|
|
HTBK
2257
DELISTED
Heritage Commerce
HTBK
| $925K | ﹤0.01% |
79,530
+2,110
| +3% | +$23.6K |
|
2258
Utz Brands
UTZ
$1.25B
| $924K | ﹤0.01% |
53,955
+1,464
| +3% | +$29.7K |
|
|
MGI
2259
DELISTED
MoneyGram International, Inc. New
MGI
| $924K | ﹤0.01% |
115,258
+9,500
| +9% | +$90.5K |
|
2260
Genco Shipping & Trading
GNK
$1.1B
| $923K | ﹤0.01% |
45,874
+1,400
| +3% | +$25.9K |
|
2261
Pulmonx
LUNG
$87.6M
| $921K | ﹤0.01% |
25,590
+1,247
| +5% | +$49.1K |
|
2262
Great Southern Bancorp
GSBC
$878M
| $919K | ﹤0.01% |
16,771
-6,500
| -28% | -$343K |
|
2263
1-800-Flowers.com
FLWS
$258M
| $913K | ﹤0.01% |
29,923
+1,171
| +4% | +$37K |
|
2264
Replimune Group
REPL
$1.01B
| $909K | ﹤0.01% |
30,659
+2,206
| +8% | +$71.6K |
|
|
PAYA
2265
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $909K | ﹤0.01% |
83,628
+3,714
| +5% | +$40K |
|
2266
Beazer Homes USA
BZH
$907M
| $907K | ﹤0.01% |
52,556
+1,271
| +2% | +$22.7K |
|
2267
Modine Manufacturing
MOD
$10.4B
| $907K | ﹤0.01% |
80,021
+1,020
| +1% | +$14.2K |
|
2268
First Mid Bancshares
FMBH
$1.36B
| $906K | ﹤0.01% |
22,062
+505
| +2% | +$20.3K |
|
|
NGM
2269
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $903K | ﹤0.01% |
42,937
+2,107
| +5% | +$46.4K |
|
2270
Aspen Aerogels
ASPN
$518M
| $901K | ﹤0.01% |
19,588
+2,067
| +12% | +$81.9K |
|
|
ALX
2271
Alexander's
ALX
$1.41B
| $900K | ﹤0.01% |
3,454
+72
| +2% | +$19.3K |
|
2272
ImmunityBio
IBRX
$8.1B
| $900K | ﹤0.01% |
92,408
+3,268
| +4% | +$36K |
|
|
OLP
2273
One Liberty Properties
OLP
$527M
| $900K | ﹤0.01% |
29,506
+680
| +2% | +$20.7K |
|
2274
IDEAYA Biosciences
IDYA
$3.56B
| $899K | ﹤0.01% |
35,260
+5,889
| +20% | +$138K |
|
2275
uniQure
QURE
$3.22B
| $899K | ﹤0.01% |
+28,094
| New | +$856K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.